The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Moxham Christopher since 2021.
This trader's CIK number is 1843784.
At the time of last reporting, Moxham Christopher was the Chief Scientific Officer of Fulcrum Therapeutics, Inc.. (stock ticker symbol FULC).
Also see all insider trading activities at Fulcrum Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | FULC | 0 | $0 | 51,785 | $906,237 | 51,785 | $405,994 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-08-10 | FULC | Sale | 51,785 | 17.50 | 906,237 |
| 2021-08-10 | FULC | Option Ex | 51,785 | 7.84 | 405,994 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Moxham Christopher (Chief Scientific Officer of Fulcrum Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.